$2.06 Million in Sales Expected for Altimmune, Inc. (NASDAQ:ALT) This Quarter
Wall Street analysts expect Altimmune, Inc. (NASDAQ:ALT – Get Rating) to report $2.06 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Altimmune’s earnings. The lowest sales estimate is $200,000.00 and the highest is $5.00 million. Altimmune reported sales of $840,000.00 during the same quarter last […]